PT  - JOURNAL ARTICLE
AU  - Carrión, Daniel
AU  - Colicino, Elena
AU  - Pedretti, Nicolo Foppa
AU  - Rush, Johnathan
AU  - DeFelice, Nicholas
AU  - Just, Allan C.
TI  - Assessing capacity to social distance and neighborhood-level health disparities during the COVID-19 pandemic
AID  - 10.1101/2020.06.02.20120790
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.02.20120790
4099  - http://medrxiv.org/content/early/2020/06/04/2020.06.02.20120790.short
4100  - http://medrxiv.org/content/early/2020/06/04/2020.06.02.20120790.full
AB  - The COVID-19 pandemic has yielded disproportionate impacts on communities of color in New York City (NYC). Researchers have noted that social disadvantage may result in limited capacity to socially distance, and consequent disparities. Here, we investigate the role of neighborhood social disadvantage on the ability to socially distance, infections, and mortality. We combine Census Bureau and NYC open data with SARS-CoV-2 testing data using supervised dimensionality-reduction with Bayesian Weighted Quantile Sums regression. The result is a ZIP code-level index with relative weights for social factors facilitating infection risk. We find a positive association between neighborhood social disadvantage and infections, adjusting for the number of tests administered. Neighborhood infection risk is also associated with capacity to socially isolate, as measured by NYC subway data. Finally, infection risk is associated with COVID-19-related mortality. These analyses support that differences in capacity to socially isolate is a credible pathway between disadvantage and COVID-19 disparities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grant UL1TR001433 and P30ES023515. DC is funded by NIH T32HD049311.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available and their sources are referenced.